Essex Management, an Emmes Group company, has appointed David Loose as Chief Executive Officer (CEO), effective immediately.

Increases speed to market for drug developers working on nucleic acid therapeutics.

Mytos has entered into a manufacturing collaboration with Aspen Neuroscience Inc. to automate the manufacturing of autologous ...

Antag Therapeutics, a biopharmaceutical company pioneering novel treatments for obesity, has appointed Joerg Moeller, MD, PhD ...

NorthStar Medical Radioisotopes, LLC and YAP Therapeutics, Inc. have formed a partnership to develop and manufacture ...

Galapagos plans to discontinue its small molecule discovery programs and seek potential partners to take over these assets, ...

The companies entered the agreement in 2023 to jointly advance as many as 11 drug programs, mainly targeting cardiovascular ...

Mytos, a provider of automated cell manufacturing, has entered a manufacturing collaboration with Aspen Neuroscience, Inc. to ...

Canyon Labs, a leader in analytical & packaging lab testing and consulting for medical devices and pharmaceuticals, has ...

Tarsier Pharma, Ltd, a late-clinical stage ophthalmic biopharmaceutical company focused on developing and commercializing ...

Merck KGaA, Darmstadt, Germany, a leading science and technology company, has adopted Quris’ Bio-AI clinical prediction ...

Innovent Biologics Inc., a biopharmaceutical company that develops, manufactures and commercializes medicines, has entered a ...